Skip to main content
Fig. 16 | Molecular Cancer

Fig. 16

From: Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics

Fig. 16

Representation of chemo-immuno-responsive effect of HO1-inhibiting hybrid nanoparticle against acute myeloid leukemia (AML). The nanoparticles show active targeting effect upon sFVA modification while are passively targeted via electrostatic interaction with the cell membrane causing phagocytic uptake. The figure is reproduced under the terms of the Creative Commons CC BY license. Copyright John Wiley and Sons [284]

Back to article page